Jorge Abreu is not a doctor. This is an educational research summary, not a prescription or a personal dosing plan. Study results do not establish that a supplier product is safe or effective for people. Consult a licensed clinician about medical decisions.
01What GHK-Cu's evidence covers
GHK-Cu is a naturally occurring copper-binding tripeptide studied for roles in skin remodeling, antioxidant activity and extracellular matrix support. A 2026 study reported results for GHK-Cu combined with a bacterial ferment extract, not GHK-Cu tested alone, which limits how directly that result applies to a single-ingredient GHK-Cu product.
02What AHK-Cu's evidence covers
AHK-Cu (L-alanyl-L-histidyl-L-lysine copper complex) was studied directly in an ex vivo human hair follicle organ culture and in cultured human dermal papilla cells. That is a narrower application, aimed at hair rather than general skin, but the study design tested the compound itself rather than a combination product.
03Why they are not substitutes
General skin remodeling and hair follicle biology are related but distinct research questions. Choosing GHK-Cu for a hair-related goal, or AHK-Cu for a general skin goal, extends each compound's evidence past what was actually measured.
Bottom line: Match the compound to the actual research question, skin matrix and antioxidant support for GHK-Cu, hair follicle and dermal papilla biology for AHK-Cu, and note that the newest GHK-Cu data point is a combination result, not a standalone one.
Read the full guides
Limited direct evidence↗
Repair and tissue research
GHK-Cu is best supported as a topical cosmetic ingredient studied in dermatology research; it is not an FDA approved drug for injectable use. Cosmetic-grade topical products and supplier research-chemical vials are different formulations and are not interchangeable based on the sources reviewed.
Read the research →
Limited direct evidence↗
Repair and tissue research
AHK-Cu is a distinct tripeptide-copper complex, structurally related to but not identical to GHK-Cu. It is not an FDA approved drug. The primary study identified used ex vivo human hair follicle organ culture and in vitro dermal papilla cell culture, not living human subjects or an animal model.
Read the research →
Reign Peptide · Business disclosure
Research product listings
Jorge Abreu is involved in Reign Peptide. Links to Reign are a business connection, not an independent endorsement. Reign lists these products for laboratory research, not human consumption.
Use the listing to check the labeled identity, amount and available batch documentation. A purity result alone does not verify sterility, clinical suitability or equivalence to a medicine used in a trial.
Names and sizes are product labels, not dosing recommendations. Confirm current details with the seller.